Fraxodi

Fraxodi is a subcutaneous injection containing Nadroparin Calcium, an anticoagulant used to prevent blood clots. It is commonly prescribed for conditions requiring blood thinning, such as deep vein thrombosis or post-surgical care.

Fraxodi is primarily used to prevent and treat blood clots in the veins, a condition known as deep vein thrombosis (DVT). It may also be used to prevent clots during certain medical procedures or surgeries. The active ingredient, Nadroparin Calcium, works by thinning the blood to reduce the risk of clots forming. This medication is often prescribed for patients who are at risk of developing clots due to prolonged immobility, surgery, or other medical conditions.

Common effects of Fraxodi may include bruising, redness, or swelling at the injection site. Some users might experience mild nausea or headache. These effects are generally mild and temporary. However, if any severe or persistent side effects occur, it is important to consult a healthcare professional.

Fraxodi should be handled with care, ensuring proper storage and administration as directed. It is important to follow the prescribed dosage and administration instructions to minimize the risk of adverse effects. Patients with a history of bleeding disorders or allergies to heparin should inform their healthcare provider before using Fraxodi.

Fraxodi may interact with other medications that affect blood clotting, such as warfarin or non-steroidal anti-inflammatory drugs (NSAIDs). It is also important to avoid alcohol while using this medication, as it can increase the risk of bleeding. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.